This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Ochsner Multi-Organ Transplant Institute Named No. 1 In The Nation For Liver Transplants

NEW ORLEANS, Jan. 28, 2013 /PRNewswire/ -- CareChex, a division of The Delta Group specializing in rating the quality of hospital and physician care, has named the Ochsner Multi-Organ Transplant Institute number one in the country for liver transplants in its 2013 Hospital ratings. This prestigious distinction recognizes Ochsner as the top hospital in the nation out of over 100 hospitals rated for liver transplants.

The CareChex Medical Quality Rating System provides a comprehensive, multi-dimensional analysis of medical quality. It incorporates multiple peer-reviewed methodologies which specifically address key components of the quality of inpatient care. The methods for the clinical category of Liver Transplant encompass the following quality measures:

  • Patient Safety Indicators
  • Mortality Rates
  • Complication Rates

"Receiving this recognition is a true testament to our innovation and dedication to excellence we have instituted since inception," said George Loss, Jr., MD, PhD, FACS, System Chair, Department of Surgery, Chief of Ochsner Multi-Organ Transplant Institute. "Our ability to research new technologies and procedures prepares us to meet the future needs of patients from across the country."

"CareChex allows the public to make informed decisions regarding the quality of medical and surgical care provided by hospitals," said Dr. Thane Forthman, managing principal at The Delta Group. "We are pleased to acknowledge that Ochsner has achieved an exceptionally high level of performance, especially in the area of medical excellence for Liver Transplants. Ochsner is a benchmark that other hospitals should seek to emulate."

Ochsner's comprehensive team consists of transplant surgeons, physicians and support specialists who have performed more than 4,500 liver, pancreas, kidney, heart and lung transplants. In 2012, more than 2,900 patients were referred to Ochsner as potential transplant candidates and 356 of those transplant procedures were performed.

"Our team uses a multi-disciplinary approach across the entire system which contributes to our transplant successes," said Nigel Girgrah, MD, PhD, Head of Hepatology, Medical Director of the Multi-Organ Transplant Institute. "This accolade is further proof that we have the right people and processes in place to provide high quality care for these patients."

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs